BioCardia, Inc. Depreciation
BioCardia, Inc. (BCDA) reported Depreciation of $24.00 thousand for the 12-month period ending 2025-12-31, per its 10-K filed 2026-03-24.
Financial Statements › Cash Flow › Operating Activities
us-gaap:Depreciation · last filed 2026-03-24
- BioCardia, Inc. depreciation for the quarter ending 2025-12-31 was $3.00K, a 80.00% decline year-over-year.
- BioCardia, Inc. depreciation for the quarter ending 2025-09-30 was $4.00K, a 75.00% decline year-over-year.
- BioCardia, Inc. depreciation for the quarter ending 2025-06-30 was $5.00K, a 70.59% decline year-over-year.
- BioCardia, Inc. depreciation for the quarter ending 2025-03-31 was $12.00K, a 36.84% decline year-over-year.
- BioCardia, Inc. depreciation for fiscal 2025 was $24.00K, a 64.18% decline from fiscal 2024.
- BioCardia, Inc. depreciation for fiscal 2024 was $67.00K, a 20.24% decline from fiscal 2023.
- BioCardia, Inc. depreciation for fiscal 2023 was $84.00K, a 2.44% increase from fiscal 2022.
- BioCardia, Inc. depreciation for fiscal 2022 was $82.00K, a 36.67% increase from fiscal 2021.
| Period end | Depreciation 3 month | Depreciation 3 month as first filed | Depreciation 6 month | Depreciation 6 month as first filed | Depreciation 9 month | Depreciation 12 month | Depreciation 15 month |
|---|---|---|---|---|---|---|---|
| 2025-12-31 | $3.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $7.00K derived: sum of 2 quarters · filed 2026-03-24 | $12.00K derived: sum of 3 quarters · filed 2026-03-24 | $24.00K 10-K · filed 2026-03-24 | |||
| 2025-09-30 | $4.00K 10-Q · filed 2025-11-12 | $9.00K derived: sum of 2 quarters · filed 2025-11-12 | $21.00K 10-Q · filed 2025-11-12 | $36.00K derived: sum of 4 quarters · filed 2026-03-24 | |||
| 2025-06-30 | $5.00K 10-Q/A · filed 2025-10-29 | $17.00K 10-Q/A · filed 2025-10-29 | $32.00K derived: sum of 3 quarters · filed 2026-03-24 | $48.00K derived: sum of 4 quarters · filed 2026-03-24 | |||
| 2025-03-31 | $12.00K 10-Q · filed 2025-05-14 | $27.00K derived: sum of 2 quarters · filed 2026-03-24 | $43.00K derived: sum of 3 quarters · filed 2026-03-24 | $60.00K derived: sum of 4 quarters · filed 2026-03-24 | |||
| 2024-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2026-03-24 | $31.00K derived: sum of 2 quarters · filed 2026-03-24 | $48.00K derived: sum of 3 quarters · filed 2026-03-24 | $67.00K 10-K · filed 2026-03-24 | |||
| 2024-09-30 | $16.00K 10-Q · filed 2025-11-12 | $33.00K derived: sum of 2 quarters · filed 2025-11-12 | $52.00K 10-Q · filed 2025-11-12 | $72.00K derived: sum of 4 quarters · filed 2025-11-12 | |||
| 2024-06-30 | $17.00K 10-Q/A · filed 2025-10-29 | $36.00K 10-Q/A · filed 2025-10-29 | $56.00K derived: sum of 3 quarters · filed 2025-10-29 | $77.00K derived: sum of 4 quarters · filed 2025-10-29 | |||
| 2024-03-31 | $19.00K 10-Q · filed 2025-05-14 | $39.00K derived: sum of 2 quarters · filed 2025-05-14 | $60.00K derived: sum of 3 quarters · filed 2025-05-14 | $81.00K derived: sum of 4 quarters · filed 2025-05-14 | |||
| 2023-12-31 | $20.00K derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-26 | $41.00K derived: sum of 2 quarters · filed 2025-03-26 | $62.00K derived: sum of 3 quarters · filed 2025-03-26 | $84.00K 10-K · filed 2025-03-26 | |||
| 2023-09-30 | $21.00K 10-Q · filed 2024-11-13 | $42.00K derived: sum of 2 quarters · filed 2024-11-13 | $64.00K 10-Q · filed 2024-11-13 | $85.00K derived: sum of 4 quarters · filed 2024-11-13 | |||
| 2023-06-30 | $21.00K 10-Q · filed 2024-08-13 | $16.00K 10-Q · filed 2023-08-09 | $43.00K 10-Q · filed 2024-08-13 | $32.00K 10-Q · filed 2023-08-09 | $64.00K derived: sum of 3 quarters · filed 2024-08-13 | $93.00K derived: sum of 4 quarters · filed 2024-08-13 | |
| 2023-03-31 | $22.00K 10-Q · filed 2024-05-14 | $43.00K derived: sum of 2 quarters · filed 2024-05-14 | $72.00K derived: sum of 3 quarters · filed 2024-05-14 | $93.00K derived: sum of 4 quarters · filed 2024-05-14 | $22.00K 10-Q · filed 2023-05-10 | ||
| 2022-12-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-27 | $50.00K derived: sum of 2 quarters · filed 2024-03-27 | $71.00K derived: sum of 3 quarters · filed 2024-03-27 | $82.00K 10-K · filed 2024-03-27 | |||
| 2022-09-30 | $29.00K 10-Q · filed 2023-11-08 | $50.00K derived: sum of 2 quarters · filed 2023-11-08 | $61.00K 10-Q · filed 2023-11-08 | $81.00K derived: sum of 4 quarters · filed 2023-11-08 | |||
| 2022-06-30 | $21.00K 10-Q · filed 2023-08-09 | $16.00K 10-Q · filed 2022-08-10 | $43.00K 10-Q · filed 2023-08-09 | $32.00K 10-Q · filed 2022-08-10 | $52.00K derived: sum of 3 quarters · filed 2023-08-09 | $67.00K derived: sum of 4 quarters · filed 2023-08-09 | |
| 2022-03-31 | $16.00K 10-Q · filed 2022-05-11 | $31.00K derived: sum of 2 quarters · filed 2023-03-29 | $46.00K derived: sum of 3 quarters · filed 2023-03-29 | $62.00K derived: sum of 4 quarters · filed 2023-03-29 | $16.00K 10-Q · filed 2023-05-10 | ||
| 2021-12-31 | $15.00K derived: 10-K 12 month − 10-Q 9 month · filed 2023-03-29 | $30.00K derived: sum of 2 quarters · filed 2023-03-29 | $46.00K derived: sum of 3 quarters · filed 2023-03-29 | $60.00K 10-K · filed 2023-03-29 | |||
| 2021-09-30 | $15.00K 10-Q · filed 2022-11-09 | $31.00K derived: sum of 2 quarters · filed 2022-11-09 | $45.00K 10-Q · filed 2022-11-09 | $61.00K derived: sum of 4 quarters · filed 2022-11-09 | |||
| 2021-06-30 | $16.00K 10-Q · filed 2022-08-10 | $30.00K 10-Q · filed 2022-08-10 | $46.00K derived: sum of 3 quarters · filed 2022-08-10 | $61.00K derived: sum of 4 quarters · filed 2022-08-10 | |||
| 2021-03-31 | $14.00K 10-Q · filed 2022-05-11 | $30.00K derived: sum of 2 quarters · filed 2022-05-11 | $45.00K derived: sum of 3 quarters · filed 2022-05-11 | $67.00K derived: sum of 4 quarters · filed 2022-05-11 | |||
| 2020-12-31 | $16.00K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-29 | $31.00K derived: sum of 2 quarters · filed 2022-03-29 | $53.00K derived: sum of 3 quarters · filed 2022-03-29 | $68.00K 10-K · filed 2022-03-29 | |||
| 2020-09-30 | $15.00K 10-Q · filed 2021-11-10 | $37.00K derived: sum of 2 quarters · filed 2021-11-10 | $52.00K 10-Q · filed 2021-11-10 | $92.00K derived: sum of 4 quarters · filed 2021-11-10 | |||
| 2020-06-30 | $22.00K 10-Q · filed 2021-08-12 | $36.00K 10-Q · filed 2021-08-12 | $77.00K derived: sum of 3 quarters · filed 2021-08-12 | $106.00K derived: sum of 4 quarters · filed 2021-08-12 | |||
| 2020-03-31 | $22.00K 10-Q · filed 2021-05-13 | $55.00K derived: sum of 2 quarters · filed 2021-05-13 | $84.00K derived: sum of 3 quarters · filed 2021-05-13 | $110.00K derived: sum of 4 quarters · filed 2021-05-13 | |||
| 2019-12-31 | $33.00K derived: 10-K 12 month − 10-Q 9 month · filed 2021-03-30 | $62.00K derived: sum of 2 quarters · filed 2021-03-30 | $88.00K derived: sum of 3 quarters · filed 2021-03-30 | $111.00K 10-K · filed 2021-03-30 | |||
| 2019-09-30 | $29.00K 10-Q · filed 2020-11-10 | $55.00K derived: sum of 2 quarters · filed 2020-11-10 | $78.00K 10-Q · filed 2020-11-10 | $100.00K derived: sum of 4 quarters · filed 2020-11-10 | |||
| 2019-06-30 | $26.00K 10-Q · filed 2020-08-13 | $49.00K 10-Q · filed 2020-08-13 | $71.00K derived: sum of 3 quarters · filed 2020-08-13 | $93.00K derived: sum of 4 quarters · filed 2020-08-13 | |||
| 2019-03-31 | $23.00K 10-Q · filed 2020-05-15 | $45.00K derived: sum of 2 quarters · filed 2020-05-15 | $67.00K derived: sum of 3 quarters · filed 2020-05-15 | $89.00K derived: sum of 4 quarters · filed 2020-05-15 | |||
| 2018-12-31 | $22.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-09 | $44.00K derived: sum of 2 quarters · filed 2020-04-09 | $66.00K derived: sum of 3 quarters · filed 2020-04-09 | $88.00K 10-K · filed 2020-04-09 | |||
| 2018-09-30 | $22.00K 10-Q · filed 2019-11-19 | $44.00K derived: sum of 2 quarters · filed 2019-11-19 | $66.00K 10-Q · filed 2019-11-19 | $87.00K derived: sum of 4 quarters · filed 2020-04-09 | |||
| 2018-06-30 | $22.00K 10-Q · filed 2019-08-14 | $44.00K 10-Q · filed 2019-08-14 | $65.00K derived: sum of 3 quarters · filed 2020-04-09 | $86.00K derived: sum of 4 quarters · filed 2020-04-09 | |||
| 2018-03-31 | $22.00K 10-Q · filed 2019-05-15 | $43.00K derived: sum of 2 quarters · filed 2020-04-09 | $64.00K derived: sum of 3 quarters · filed 2020-04-09 | $87.00K derived: sum of 4 quarters · filed 2020-04-09 | |||
| 2017-12-31 | $21.00K derived: 10-K 12 month − 10-Q 9 month · filed 2020-04-09 | $42.00K derived: sum of 2 quarters · filed 2020-04-09 | $65.00K derived: sum of 3 quarters · filed 2020-04-09 | $78.00K 10-K · filed 2020-04-09 | |||
| 2017-09-30 | $21.00K 10-Q · filed 2017-11-09 | $44.00K derived: sum of 2 quarters · filed 2017-11-09 | $57.00K 10-Q · filed 2017-11-09 | $66.00K derived: sum of 4 quarters · filed 2019-04-02 | |||
| 2017-06-30 | $23.00K 10-Q · filed 2017-08-14 | $36.00K 10-Q · filed 2017-08-14 | $45.00K derived: sum of 3 quarters · filed 2019-04-02 | $54.00K derived: sum of 4 quarters · filed 2019-04-02 | |||
| 2017-03-31 | $13.00K 10-Q · filed 2018-05-10 | $22.00K derived: sum of 2 quarters · filed 2019-04-02 | $31.00K derived: sum of 3 quarters · filed 2019-04-02 | $42.00K derived: sum of 4 quarters · filed 2019-04-02 | |||
| 2016-12-31 | $9.00K derived: 10-K 12 month − 10-Q 9 month · filed 2019-04-02 | $18.00K derived: sum of 2 quarters · filed 2019-04-02 | $29.00K derived: sum of 3 quarters · filed 2019-04-02 | $39.00K 10-K · filed 2019-04-02 | |||
| 2016-09-30 | $9.00K 10-Q · filed 2017-11-09 | $20.00K derived: sum of 2 quarters · filed 2017-11-09 | $30.00K 10-Q · filed 2017-11-09 | ||||
| 2016-06-30 | $11.00K 10-Q · filed 2017-08-14 | $21.00K 10-Q · filed 2017-08-14 | |||||
| 2016-03-31 | $10.00K 10-Q · filed 2017-05-11 | ||||||
| 2015-12-31 | $47.00K 10-K · filed 2018-03-16 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| DYADIC INTERNATIONAL INC (DYAI) | United States | $0.016B | |
| Passage BIO, Inc. (PASG) | United States | $0.015B | -0.43 |
| Pluri Inc. (PLUR) | $0.014B | ||
| INTENSITY THERAPEUTICS, INC. (INTS) | United States | $0.013B | -1.08 |
| BRAINSTORM CELL THERAPEUTICS INC. (BCLI) | United States | $0.013B | -1.05 |
| Jasper Therapeutics, Inc. (JSPR) | United States | $0.020B | -0.37 |
| Estrella Immunopharma, Inc. (ESLA) | United States | $0.020B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |